Contribution through Business Activities | Sustainability | Asahi Kasei

Contribution through Business Activities

In fiscal 2022, the Asahi Kasei Group launched its three-year Medium-term Management Plan centered on sustainability focused on the theme "Be a Trailblazer." In order to contribute to building a sustainable society, Asahi Kasei will continue contributing to the solutions of diverse social issues through our business activities.

In our medium-term management initiative, we continue to expressed the stance of the Asahi Kasei Group, which will continue contributing to sustainable development for people and the Earth going forward, in the phrase “Care for People, Care for Earth.” With this as a perspective on the provision of value that is shared throughout our business activities, we will create new value that leads to a sustainable future in diverse locations and fields.

  • Care for Earth/Achievement of a carbon neutral sustainable worldCare for People/Active life in the new normal[Issues Asahi Kasei is Working to Address]Carbon neutral/circular economy Safe, comfortable, and eco-friendly mobilityMore comfortable and convenient livesHomes and communities that enrich peopleA society with active, healthy longevity[Fields Where Asahi Kasei Can Provide Value]Environment & Energy/Mobility/Life Material/Home & Living/Health Care [Material][Homes][Health Care]

Areas of Contribution and Business Examples

  • *Under development
Fields for provision of value Care for People Care for Earth
Material Environment & Energy

Clean energy

Conservation of energy and improvement of the environment

Contribution to low-carbon society

  • Next-generation CO2 chemistry*
  • New CO2 separation and recovery system*
Mobility

Safety and reliability

Comfortable space

Fuel efficiency

EV/HEV

Life Material

Comfort and convenience

Health

Food loss reduction and low environmental impact

Homes Home & Living

Safety and reliability/Comfort and health

Contribution to the environment

Health Care Health Care

Acute conditions (critical care and circulatory)

Chronic conditions (orthopedics and dialysis)

Provision of safe biopharmaceuticals